Bioregulators - PeptideBlog

Bioregulators

Research area

Bioregulators

Short peptide fragments originally developed in Soviet-era research, studied for tissue- and organ-specific regulatory effects. Evidence for this entire class is thin by modern clinical standards -- most of what exists is older animal and observational research.

14 entries in this category.

  • Bronchogen

    Bronchogen is a Khavinson-family peptide marketed as a bronchial/respiratory bioregulator; its identity overlaps confusingly with the related product Chonluten across vendor sources.

  • Cardiogen

    An educational profile of Cardiogen, a Khavinson-family "bioregulator" peptide marketed for cardiac support, documenting significant sequence conflicts across sources, an unresolved relationship to "Cardiogen-3," and the absence of confirmed cardiac-tissue research.

  • Cartalax

    An educational profile of Cartalax (Ala-Glu-Asp tripeptide), a Khavinson-school "bioregulator" marketed for cartilage support, covering its laboratory evidence, unverified oral dosing claims, and lack of human trials.

  • Chonluten

    Chonluten is a Khavinson-family peptide marketed for bronchopulmonary support; its chemical distinction from the related Bronchogen product is unresolved in available sources.

  • Cortagen

    Cortagen is a Khavinson-family peptide marketed as a cerebral cortex bioregulator, distinct from the unrelated animal-extract product Cortexin, with minimal independent research behind it.

  • Crystagen

    Crystagen is a Khavinson-family peptide marketed as an immune bioregulator, distinct from but poorly differentiated in available sources from Vilon and Thymogen.

  • Livagen

    Livagen is a short Khavinson-family synthetic peptide marketed as a liver bioregulator, sold as an oral supplement with minimal independent research behind it.

  • Ovagen

    Ovagen is a Khavinson-family peptide most commonly marketed as an ovarian/reproductive bioregulator, though vendor sources inconsistently and sometimes conflictingly describe its organ target.

  • Pancragen

    Pancragen is a Khavinson-family peptide marketed as a pancreatic bioregulator; vendor claims sometimes extend to diabetes or pancreatitis without supporting clinical evidence.

  • Pinealon

    An educational profile of Pinealon (Glu-Asp-Arg tripeptide), a Khavinson-school "bioregulator" marketed for brain/pineal support, covering its animal and human-cell evidence, unverified oral dosing claims, and lack of human trials.

  • Prostamax

    An educational profile of Prostamax, a Khavinson-family "bioregulator" peptide marketed for prostate support, documenting the near-total absence of independently verifiable sequence, mechanism, and dosing data.

  • Testagen

    An educational profile of Testagen, a Khavinson-family "bioregulator" peptide marketed for testicular/reproductive support, documenting the near-total absence of independently verifiable sequence, mechanism, and dosing data.

  • Vesugen

    An educational profile of Vesugen (Lys-Glu-Asp tripeptide), a Khavinson-school "bioregulator" marketed for vascular support, covering its cell-culture evidence, a sequence conflict across sources, and unverified dosing claims.

  • Vilon

    An educational profile of Vilon (Lys-Glu dipeptide), a Khavinson-school "bioregulator" marketed for immune/thymic support, covering its animal and human skin-cell evidence, unverified oral dosing claims, and lack of human trials.